Instrument Inactif

Communiqués Endonovo Therapeutics Inc OTC Bulletin Board

Actions

US4111551044

Recherche biotechnologique et médicale

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

29/12/23	Endonovo Therapeutics, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2023	CI
12/10/23	Sofpulse® d'Endonovo Therapeutics, Inc. obtient l'approbation de la FDA de Taiwan	CI

Communiqués

28/03/24	Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc	AQ
04/03/24	Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions	AQ
04/12/23	Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million	AQ
12/10/23	Endonovo's SofPulse® Secures Taiwan FDA Approval	AQ
22/08/23	Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution	AQ
08/08/23	Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update	AQ
22/06/23	New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.	AQ
07/06/23	Endonovo Pending Agreement to Develop Telehealth Division	AQ
02/05/23	Endonovo Launches SofPulse® into the Veterans Administration	AQ
25/04/23	Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies	AQ
17/04/23	ENDONOVO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
13/04/23	Endonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Lineman	AQ
10/04/23	Endonovo Announces Partnership with Santana Lead Singer Andy Vargas	AQ
29/03/23	Endonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Company	AQ
29/03/23	ENDONOVO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
23/03/23	Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan	AQ
15/03/23	Olympian and Champion Surfer Carlos Muñoz Turns To SofPulse® For Accelerated Recovery After Invasive Shoulder Surgery	AQ
06/03/23	Endonovo Announces Distribution Agreement with Academy Medical	AQ
28/02/23	Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg	AQ
31/01/23	Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off	AQ
26/01/23	Endonovo Partners with International Distributor for SofPulse® Line	AQ
19/01/23	New Details on Endonovo’s Spin-Off of SofPulse, Inc.	AQ
09/01/23	Endonovo Therapeutics Details Plan to Spin Off Medical Device Division as a Listed Public Company	AQ
03/01/23	Endonovo Targets Dept. of Defense, VA & Federal Contracts	AQ
19/12/22	Endonovo Announces Advancement of International “Go to Market” Initiative	AQ